It is important to set the right tone early in Clinical Trial Agreement negotiations to ensure your project isn’t relegated to the back of your counterpart’s queue. However, CTA negotiations are often derailed before they can even get going due to poor, unreasonable template drafting by the Sponsor/CRO or over-redlining by the site. In this session, the speakers will explore some common CTA template language and redlining practices that can be corrected to promote more efficient CTA negotiations for all parties